It is a pharma public limited company based in Pune, Maharashtra, India, established in 1994.
1994 | Pune, Maharashtra, India | ActiveNeutralizer Pharmaceuticals Limited, a active public limited company, was established on 05 October 1994 in Pune, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH1994PLC071053. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.66 M.
Formerly known as Vardhaman Drugs Ltd. It upholds a compliant status. Its leadership includes Sunil Dharamchand Shah (Director), Ajay Namdevrao Jadhav (Director), Avinash Wadgaonkar (Director). Past directors included Dharamchand Shah Bhikubhai, Sunil Dharamchand Shah, Sumedh Dharamchand Shah. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Flat No.07, Poorva Apartmen Sr No.1556, Shivaji Nagar Pune, Pune, Maharashtra, 411005.
U24239MH1994PLC071053
071053
05 October 1994
₹1.00 Cr
₹0.66 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Neutralizer Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Dharamchand Shah | Director | 05 Oct 1994 | Current |
| Ajay Namdevrao Jadhav | Director | 29 May 2020 | Current |
| Avinash Wadgaonkar | Director | 29 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 May 2020 | Past |
| Pramod Abcsdd | Managing Director | 27 Oct 2016 | Past |
| Pramod Abcsdd | Director | 14 Jun 2011 | Past |
| Pramod Abcsdd | Director | 14 Jun 2011 | Past |
| Pramod Abcsdd | Director | 29 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neutralizer Pharmaceuticals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 12.12% decrease in profit. The company's net worth dipped by a decrease of 4.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Neutralizer Pharmaceuticals had a promoter holding of 89.05% and a public holding of 10.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neutralizer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neutralizer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neutralizer Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neutralizer Pharmaceuticals Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Ajay Namdevrao Jadhav was appointed as a Director was appointed as a Director on 29 May 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
Progress on Avinash Wadgaonkar was appointed as a Director was appointed as a Director on 29 May 2020 & has been associated with this company since 5 years 6 months . was documented.
The activity Neutralizer Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was completed.
The activity Sunil Dharamchand Shah was appointed as a Director was appointed as a Director on 05 Oct 1994 & has been associated with this company since 31 years 1 month . was completed.
Progress on Neutralizer Pharmaceuticals Limited was registered on 05 Oct 1994 with Roc Pune & aged 31 years 1 month as per MCA records. was documented.
The CIN of Neutralizer Pharmaceuticals Limited is U24239MH1994PLC071053.
Neutralizer Pharmaceuticals Limited is headquartered at Flat No.07, Poorva Apartmen Sr No.1556, Shivaji Nagar Pune, Pune, Maharashtra, 411005.
Neutralizer Pharmaceuticals Limited was incorporated on 05 October 1994.
The current directors of Neutralizer Pharmaceuticals Limited are
The primary industry of Neutralizer Pharmaceuticals Limited is Pharma.
Neutralizer Pharmaceuticals Limited is unlisted.
The authorized capital of Neutralizer Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹0.66 M.
The compliance status of Neutralizer Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX